Stock 0QQD ZIMMER BIOMET HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Zimmer Biomet Holdings, Inc. London S.E.

Equities

0QQD

US98956P1021

Market Closed - London S.E.
Other stock markets
 14:41:26 29/01/2021 GMT 		5-day change 1st Jan Change
136.1 CHF +6.20% Intraday chart for Zimmer Biomet Holdings, Inc. -.--% -.--%
06-20 Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors CI
06-12 Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health MT

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's high margin levels account for strong profits.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's enterprise value to sales, at 3.43 times its current sales, is high.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last few months, analysts have been revising downwards their earnings forecast.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-.--% 22.33B -
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.60% 181B
C+
MEDTRONIC PLC Stock Medtronic plc
-4.45% 101B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.15% 67.54B
A
DEXCOM, INC. Stock DexCom, Inc.
-8.63% 45.09B
B-
CENCORA, INC. Stock Cencora, Inc.
+9.70% 44.37B
B-
HOYA CORPORATION Stock Hoya Corporation
+6.13% 40.7B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.22% 29.85B
B
TERUMO CORPORATION Stock Terumo Corporation
+14.80% 24.49B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.46% 23.99B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ZBH Stock
  4. 0QQD Stock
  5. Ratings Zimmer Biomet Holdings, Inc.